Sinovac Biotech which is a provider of bio-pharmaceutical products in China has plans to accentuate the corporate governance and management of Sinovac Biotech Co., Ltd, the main operating subsidiary of Sinovac.
Sinovac Biotech has confirmed the appointment of Mr. Dawei Mao who is also the Chairman of Zhongke Biopharmaceutical Co., ltd as director of Sinovac Beijing. He has substituted Ms. Xiaomin Yang, the President of Sinobioway Group Co., Ltd.
Mr. Weidong Yin, Chairman, President and CEO of the Company, stated, “With the support of the board of directors of Sinovac Beijing, I will lead the team at Sinovac Beijing to continue to provide vaccines to eliminate human diseases.”